Academic Achievement in Children With Asthma

NCT02228499 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2019-05-07

Study results available
· View outcomes & findings →

Summary

Background: Asthma is the most common chronic disease of childhood with a prevalence that is 1.6 times greater in African American children than in Non-Hispanic White children.1 Nationally, 700,000 children are seen for asthma in Emergency Departments every year, 1% of which are seen at Children's National Health System in Washington, District of Columbia. School performance and school attendance has not been well studied in urban children with asthma, especially at the middle school level.

Objective: Our purpose is to test the hypothesis that middle school children with asthma have worse school performance than middle school children without asthma in Washington DC and Prince George's county schools.

Methods: The investigators will conduct a cross-sectional observational study of middle-school (grades 6-8 in the 2013-2014 school year) aged children with and without asthma recruited from the Emergency Departments and the IMPACT DC asthma clinic at CN. The investigators will collect demographic information, asthma severity information (for cases), and request that parents mail report cards and standardized test scores directly to the investigators. The investigators will use multivariable linear and logistic regression to determine if the presence of asthma is associated with school performance.

Conditions

Interventions

OTHER

Survey

We will be administering surveys about health, quality of life, and asking for final report cards for the 2013-2014 school year for each group.

Sponsors & Collaborators

  • Shilpa Patel

    lead OTHER

Principal Investigators

  • Shilpa Patel, MD · Children's National Research Institute

Eligibility

Min Age
11 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-15
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02228499 on ClinicalTrials.gov